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Overview
It is anticipated that these state-based surveillance data will:

In 2010, the Registry and Surveillance System for
Hemoglobinopathies (RuSH) pilot project was implemented by
the Centers for Disease Control and Prevention (CDC) to collect
state-specific, population-based data on people with sickle
cell disease (SCD) and thalassemia. The pilot project is being
supported and conducted in collaboration with the National
Institutes of Health’s National Heart, Lung, and Blood Institute.

yy Provide estimates of the number of new cases (incidence) of
SCD and thalassemia each year.

yy Provide estimates of the total number of existing cases
(prevalence) of SCD and thalassemia.

yy Provide information on trends in medical care for people
with these disorders.

Overall project goals include determining the number of
people who have SCD and thalassemia and increasing
knowledge and awareness about health care use and
outcomes. Currently, seven states are funded to participate
in data collection: California, Florida, Georgia, Michigan, New
York, North Carolina, and Pennsylvania. In addition to collecting
and linking their unique data to help reach these goals, the
states also have planned and implemented health promotion
initiatives designed to increase awareness about RuSH in the
affected communities to aid in the data collection

yy Provide information about complications and death rates.
yy Provide information to assist with planning public health
interventions (i.e., services, health promotion campaigns,
health education, and training) to improve the health of
these populations.
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Strategy Field Reports
yy Connecting the Dots:

The purpose of this document is to showcase some of the
unique ways in which the states have implemented activities
designed to meet the programmatic goals of RuSH. In the
following sections, each state highlights one of their many
programs and features information about the resources
needed to operate or replicate the activity, as well as intended
benefits and outcomes, and provides a set of lessons learned
to readers. Intended aims of this document are the provision
of contact and programmatic information to other entities for
the potential modification or replication, or both, of activities.
Additionally, this document can be used to inform and
motivate appropriate community members in the creation of
a supportive environment for the RuSH program to assist the
program in moving forward.

yy Finding Our Voice:

Creating and Implementing a
Community Speaker Panel in Georgia

yy Measuring Michigan’s Health:

A Hemoglobinopathy Health

Status Assessment

yy Garnering Statewide Support for RuSH: Regional Provider
Meetings in New York

yy Faith-based Initiative: North Carolina’s Approach to
Community Outreach for Hemoglobinopathies

yy Answering the Call:

Pennsylvania’s Toll-Free Telephone
Number for Hemoglobinopathy Health Care Referrals

The RuSH program will conclude in September 2012.
Development of a strategies document highlighting
surveillance activities conducted by the participating states is in
progress.

The information in this report was provided by programmatic
team members who worked with CDC staff in fall 2011. This
document comprises the following RuSH health promotion
strategies from the field:

yy Putting the Focus on Sickle Cell:

Building a Provider Network and

Directory in Florida

Northern California’s Focus

Group and Stakeholder Meetings

yy Resource STREET: Sickle Cell Disease and Thalassemia

Resources To Educate and Empower the Community  An
Online Database Serving Southern California
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Putting the Focus on Sickle Cell:
Northern California’s Focus Group and
Stakeholder Meetings
Program Overview

sessions began. The group facilitator led the discussions
with a note-taker present, and each session was recorded
using a digital recording device. The notes were reconciled with
the recording transcripts immediately following the
focus group meetings.

Individuals with hemoglobinopathies, specifically sickle
cell disease (SCD) and thalassemia, face significant barriers
accessing health care services and participating in public
health and clinical research projects. These barriers are related,
in part, to the cultural and linguistic diversity within the
affected populations and mistrust between clients or patients
and providers, as well as social and economic barriers. These
barriers call attention to the need for increased sensitivity
and communication surrounding the initiation of new studies
and projects that might offend or stigmatize the targeted
population. To address these issues, the Northern California
RuSH education and outreach team designed focus groups
and stakeholder meetings to address the effects of RuSH
on the SCD and thalassemia communities. The primary
objective was to obtain input from stakeholders through
focus groups on how to (1) engage the SCD and thalassemia
communities with the RuSH project, (2) address potential
barriers to hemoglobinopathies surveillance, (3) assess the
appropriateness and appeal of the RuSH messaging tools, and
(4) identify additional community stakeholders who should be
engaged with the RuSH project.

Benefits
Information gathered from the stakeholder focus group
meetings is intended to provide guidance to the RuSH project
about potential barriers and perceived benefits to surveillance
and participation in a registry program. Feedback from
stakeholders has been valuable in the design, marketing, and
implementation of the RuSH project. The focus groups have
allowed the RuSH project team to foster a relationship with
affected communities, thereby influencing subsequent actions
to be transparent and consumer focused. Another benefit of
the focus groups is the opportunity to provide basic education
about hemoglobinopathies to communities that might or
might not be affected directly by the diseases or complications,
but would benefit from targeted education.

Outcomes

Resources Needed

To date, four focus groups of stakeholders have been
convened, with a total of 34 individuals participating.
Participants included the psychosocial team members of
a comprehensive sickle cell center, leadership of regional
SCD community-based organizations, individuals with
thalassemia, and staff from the local Asian Health Services
program. Participants were educated briefly about public
health surveillance and asked to respond to questions about
barriers to and facilitators of community participation in
surveillance for hemoglobinopathies. Participants reviewed
and critiqued written materials created for RuSH and identified
other important groups to target, to share RuSH messaging.

Qualitative data and clinical research expertise was used to
help design a script for the focus groups that addressed the
objectives. A standard definition of the terms “surveillance” and
“registry”, and examples of each, was presented to the groups.
Established community connections were used to compile
the invitations for initial focus group meetings. To solicit
participation in future focus groups, stakeholders were asked to
identify additional community contacts.
A convenient and comfortable meeting space was reserved
to host the focus group meetings. The meeting environment
limited external distractions, and food was provided before the
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Next Steps

Following the focus group meetings, Northern California
RuSH team members reviewed notes and audio transcripts
independently to identify common themes within and
across groups.

The Northern California RuSH education and outreach
committee continues to contact groups identified through prior
focus groups to organize new focus groups, specifically with
patients with SCD and local community SCD and thalassemia
provider groups. Focus group results were summarized in an
abstract, with plans to publish the data.

The focus groups identified common themes around
surveillance, which included concerns about who will have
access to the data and what will be done with it, and the need
to identify and communicate direct benefits to patients. Focus
group members saw RuSH as a means of educating providers
and the general community about hemoglobinopathies and
suggested customizing materials (culture and language) for
different audiences (e.g., providers, patients, communities).
Perhaps the most valuable feedback identified the potential
barriers to surveillance and registry data collection. Historic
mistrust among targeted groups and cultural mores
maintaining secrecy about the conditions were cited as
major factors. Participants also provided a diverse listing of
regional community health, provider, faith-based, social, and
academic groups that should be approached as potential
supporters of RuSH.

Contact Information
Lisa Feuchtbaum, Dr.P.H., M.P.H.
California Department of Public Health
E-mail Address: Lisa.Feuchtbaum@cdph.ca.gov
Phone: (510) 412-1455
CA RuSH Website: www.casicklecell.org

Words from the Field
“What is going to be the benefit of participating in
surveillance? Better access to care? Now, that’s a true
incentive!”
— Sickle Cell CBO Leader

Lessons Learned

“I hope that a program like [RuSH] will put more
pressure on providers to follow the standards of care
for thalassemia.”
— Thalassemia Patient

yy 15 minutes should be allotted for general education on

hemoglobinopathies at the beginning of the focus groups,
especially for groups that are further removed from health
care fields, such as cultural organizations, sororities, and
fraternities.

“Having [a] record of cases and information about
patients will show policymakers how many people are
living with thalassemia and sickle cell in this country;
real numbers. Right now, it’s vague; they think it’s
really rare. Hopefully, this will make it easier for them
to see what their constituents look like.”
— Thalassemia Patient

yy Educational

materials should be clear about the potential
effects of the RuSH project on research and health practice,
as well as specific actions the community can take to
support the RuSH project.

yy Educational materials should be customized for

diverse audiences, which includes taking into account
various language and cultural differences, audiences
and age groups.
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Resource STREET:
Sickle Cell Disease and Thalassemia Resources to
Educate and Empower the Community —
An Online Database Serving Southern California
Program Overview

requires assistance from the developer. Fees for developer
services have to be arranged through individual contracts,
and there might be fees associated with hosting the database
locally or through a common provider such as Amazon.com®.

Resource STREET is a comprehensive, online database that
manages information relevant to the community outreach
elements of the California RuSH project. In an effort to reach out
to specific communities affected by sickle cell disease (SCD) and
thalassemia, the database was created to capture and organize
available resources. The database contains information about
individuals active in sickle cell and thalassemia communities,
community organizations, institutions, and other entities
offering direct or support services to patients and their families;
it does not contain patient information.

It is important to have one or two individuals who are
knowledgeable about the system and able to answer questions
for other users designated as data managers. The data
managers ensure the accuracy and integrity of the information
and oversee data input and output.

Benefits

The database provides a central resource for RuSH staff
in Southern California, as well as for community-based
organizations that are participating in the project. There are
over 18,000 providers and 4,000 organizations and institutions
in the database.

There are significant benefits to having information in one
place, immediately accessible to users, and flexible so that users
can enter the information and create personalized groups. A
relational database provides the ability to retrieve information
in a wide variety of ways, such as:

The flexibility of the database allows for several things:

yy Providing a common repository for all contact information

for individuals or organizations whose services might be of
use to providers or patients with thalassemia or SCD.

yy Users can update information in real time.
yy People or organizations can be grouped together and

yy Providing the information in a normalized relational

marked as public or private.

database format such that queries and reports can be
generated.

yy Detailed information about an organization, such as mission

statement, programs, languages supported, and a link to the
organization’s homepage can be entered.

yy Allowing geographic localization of resources, including
medical providers.

yy Information can be shown on a map (locations of providers,

yy Allowing tracking of the effectiveness of various resources

organizations, and other resources).

and assisting hemoglobinopathy programs and patients.

yy Customized reports can be generated.
yy The database allows for queries concerning usage, such as

By providing a central repository and allowing individuals to
contribute to the database over time, the total amount of work
and time spent in locating resources throughout the state can
be reduced.

the volume of activity using each outreach method.

Resources Needed
The fundamental computer code developed for the database
is available to anyone interested in building a database with
similar components. A fundamental license for Microsoft SQL
Server® 2008 is required. Installation and setup of the database
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Outcomes

Contact Information
Lisa Feuchtbaum, Dr.P.H., M.P.H.
California Department of Public Health
E-mail Address: Lisa.Feuchtbaum@cdph.ca.gov
Phone: (510) 412-1455
CA RuSH Website: www.casicklecell.org

The database has been invaluable for generating mailing lists
to send outreach materials, surveys, and other information to
target groups of providers and organizations. The Southern
California RuSH team has also been able to connect patients
with resources available in their geographic area. A newly
created community based organization in Southern California
has expressed an interest in obtaining access to the database
and using it for project management. There are plans to
survey users for feedback on ease of use and functionality, and
suggestions for improvement.

Words from the Field
“Our Southern California sickle cell community
needed a database to manage information about
resources, and we’re glad this project happened.
We can share the information with people who
are looking for resources and those new to our SC
Community. As a sickle cell educator and health
advocate, the database has allowed me to focus my
time on other important issues for our community.”
— N.T.

Lessons Learned
Database development is a trial and error process, and it
is difficult to anticipate exactly how long each stage of
development will take. Plenty of time should be allowed to
design and redesign elements of the database, as well as for
users to adapt to the new system and receive assistance. It is
helpful to have personnel on call to field questions as they arise.

Next Steps
This database serves as a common repository of information to
identify providers, agencies, and individuals with resources for
SCD and thalassemia. Eventual implementation of a geographic
mapping module will allow patients and providers to identify
resources within a defined geographic area.
Use of this program with community-based organizations in
California will continue. Key staff members have been trained
to update the database on a regular basis, and there are plans
to continue maintaining the system.
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Connecting the Dots:
Building a Provider Network and Directory in Florida
Program Overview

Benefits

The Florida RuSH coalition formed three advisory committees,
one of which is the Community Partnership and Health
Education Committee, consisting of leaders from sickle
cell community-based organizations (CBO) and statefunded sickle cell outreach coordinators. The Community
Partnership and Health Education Committee discussed the
need for a provider directory that would serve as a referral
resource of hemoglobinopathy experts who provide care,
care coordination, counseling, education, and follow-up for
individuals with a hemoglobinopathy (sickle cell disease [SCD]
or thalassemia).

The purpose of the physician and provider directory is to assist
SCD and thalassemia patients, community-based organizations,
outreach educators, and anyone in need of locating a
hematologist with expertise in SCD and thalassemia. Thus,
benefits include increased referrals for services and support,
closing the gap between patients and services, and access to
a more comprehensive care system for hemoglobinopathy
patients and their families.

Outcomes
A notable outcome is the use of the tool by Florida CMS nurses
whose role is to provide care coordination (case management)
for CMS-eligible children from birth through 21 years of age.
CMS is a Title V program that provides care for children with
special health care needs through 22 CMS area offices. CMS
nurses have reported that this directory has assisted them in
finding adult providers for adolescent patients.

An initial task in creating such a directory was obtaining the
location of hemoglobinopathy physicians and other providers
and hospitals in Florida, in addition to other pertinent
information. The South Broward Hospital District (SBHD)
Planning and Marketing Department obtained SCD- and
thalassemia-specific data from the Agency for Healthcare
Administration (AHCA), for fiscal year 2008. AHCA is the state
agency that collects data on hospital and emergency room
discharges, surgery, and ambulatory care centers. Information
from AHCA was divided into the following categories: pediatric,
adult, inpatient, outpatient, emergency room utilization, and
physician. Data were assembled based on information from
top volume hospitals and physicians and other providers into
a Microsoft® Excel file. The directory then was shared with the
Community Partnership and Health Education Committee and
Florida’s Children’s Medical Services (CMS) hematology and
oncology centers.

Anticipated Outcomes:

yy Assists individuals with hemoglobinopathies in locating
expert providers within or close to their community.

yy Assists CMS area offices in connecting patients 18 through
21 years of age with local adult physicians and other
providers.

yy Creates a network of physicians and other providers in the
state of Florida with expertise in hemoglobinopathies.

yy Identifies gaps in geographic distribution of physicians and
other providers with hemoglobinopathy expertise.

Resources Needed

yy Identifies gaps in service location.
yy Monitors hemoglobinopathy health care usage trends.

To replicate a state- or geographic-specific physician and other
provider directory, access to the state’s health care inpatient,
outpatient, ambulatory, emergency room, and hospital
discharge data is necessary, as well as provider’s diseasespecific volume data. Minimal staff is needed to create and
maintain the directory.
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Lessons Learned

Words from the Field

An important lesson learned from the development and
dissemination of the physician directory is that there is a greater
need for such a resource than initially projected. Although the
Florida RuSH coalition generated the physician directory, it
was not immediately shared with the Community Partnership
and Health Education Committee because the coalition
was unaware of the immediate need in the sickle cell and
thalassemia communities. Communication across workgroups
and committee is a valuable tool that can create pathways from
resources to those who need them most.

“One of the biggest challenges faced by patients and
families is to identify a hematologist. The physician
and other provider directory will assist sickle cell
disease and thalassemia patients, community- based
organizations, outreach educators, and anyone else
in need of locating a hematologist with expertise in
sickle cell disease and thalassemia.”
— Lanetta Jordan, MD, MPH, MSPH,
Director, Sickle Cell Services,
Memorial Healthcare System, Florida

Next Steps
The next step will be the creation of a map of Florida
highlighting geographic locations of physicians and other
providers who treat hemoglobinopathies. Currently, Florida
is reaching out to physicians and other providers to provide
hemoglobinopathy patient data through a secure website,
as part of the data collection activities for the RuSH initiative.
When physicians and other providers sign up for the online
data collection account, they will be prompted to indicate if
their practice or services may be included on the map and in
the directory. The option to be included in the mapping system
and directory also will be offered to any other physicians or
providers. All physicians and providers who are interested in
this system will be verified using the Florida Department of
Health Provider Search website.
Contact Information
Mary Beth Vickers, RN, MSN
Florida Department of Health
Marybeth_vickers@doh.state.fl.us
(850) 245-4222
FL RuSH Website: http://www.cms-kids.com
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Finding Our Voice:
Creating and Implementing a
Community Speaker Panel in Georgia
Program Overview

Strategy #4: Use a highly regarded training curriculum
yy The Baby STEP® curriculum, created by health care
specialists from the University of Alabama, Birmingham, is
distributed to all speaker panelists for use in presentations.

The Sickle Cell Foundation of Georgia (SCFG) has a long history
of providing outreach and education to sickle cell clients
throughout the state. To extend and guide outreach efforts, the
SCFG and its partners created a speaker panel to promote the
RuSH project to sickle cell disease (SCD) clients, the community,
and health care providers. Five key strategies were used to
create and initiate the speaker panel and will be used in the
near future to train the speakers: (1) carefully select speaker
panel representatives, (2) focus on creating messaging relevant
to key audiences, (3) design materials for Spanish-speaking
audiences, (4) use a highly regarded training curriculum, and (5)
activate health care provider connections to reach additional
key audiences.

Strategy #5: Activate health care provider connections to
reach additional key audiences
yy Relationships with health care providers specializing in the
treatment of SCD are employed to facilitate connections
with other health care providers.

Benefits
Carefully selecting panel members who are also support
group leaders and crafting messages relevant to their client
audiences strengthens the connection between the RuSH
project outreach activities and the ultimate goal of improving
outcomes for clients. Designing materials for Spanish-speaking
audiences helps the speaker panel overcome language barriers.
People often share health information with their loved ones,
and information that already is translated and accessible is
more likely to be shared. Using an existing curriculum has
ensured speakers have a consistent and comprehensive
resource for background information, which has increased the
likelihood that accurate and appropriate information is shared
with target audiences. Utilizing relationships with health care
providers allows the speaker panel members to identify areas
of high need throughout the state and facilitate appropriate
connections for professional education and outreach.

Resources Needed
A variety of resources are used to implement five key strategies.
Strategy #1: Carefully select speaker panel representatives
yy Data from the RuSH project is used to identify counties with
high concentrations of individuals with SCD and racial and
ethnic groups of interest.

yy Sickle cell support groups are used to identify contacts in
counties of interest.

yy Existing and newly established relationships with

support group leaders are utilized; leaders with a strong
commitment to education and outreach are identified as
potential panel speakers.

Outcomes

yy A wide range of representatives are selected to ensure a

Georgia anticipates 15 to 20 people will complete the training
for the speaker panel in the spring of 2012. Panelists will
track the number of speaking engagements, their audiences,
and additional resources needed, and identify opportunities
for additional panel presentations. Audiences will be given
evaluation forms after participating in the panel discussions,
to comment on the panel as an additional means of ongoing
quality improvement.

variety of resources will be available.

Strategy #2: Focus on messaging relevant to key audiences
yy A deep knowledge of SCD clients and their needs and
interests helps formulate messaging.
Strategy #3: Design materials for Spanish-speaking audiences
yy Staff that specialize in outreach for this audience are
engaged to generate materials.
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Lessons learned

Contact Information
Sharon C. Quary, MS
Georgia Department of Public Health
E-mail: scquary@dhr.state.ga.us
(404) 657-4143

The process of developing the speaker panel has revealed that
SCD clients and their families are cautious of research, just
for the sake of research. Information from the RuSH project
must be relevant to the needs of clients, and offer a more
immediate response to their participation. Identifying speakers
who understand those needs and can deliver messages that
articulate the importance of improving outcomes for clients is
critical to supporting RuSH and supporting clients.

Words from the Field
“The majority of my population doesn’t know what
their hemoglobin is or why it’s important to take the
test. We educate them about sickle cell after they
know about hemoglobin.”
— Janeth Spurlin

Building and maintaining relationships with clients and those
who serve clients through support groups and health care is
essential to reaching those most in need. Translating materials
from one language to another is not sufficient; there has to be
a culturally relevant connection. Materials that creatively use
elements of Latino culture to create stories and characters for
explaining the information have been well received.

“Ten years from now, I don’t want to be doing the
same thing. We need to make real improvement for
people with sickle cell disease through education,
legislation, and economic resources.”
— Jackie George,
Sickle Cell Foundation of Georgia

Next Steps
Moving forward, the speaker panel trainings will be held in
March 2012. Creation of an evaluation form will assist in tracking
the effects of the panel on audiences. Presentation posters
will be designed and printed as visual aids, with detailed
information and data for each target area.
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Measuring Michigan’s Health:
A Hemoglobinopathy Health Status Assessment
Program Overview

Resources Needed

Newborn screening (NBS) for sickle cell disease (SCD) has
been conducted at the Michigan Department of Community
Health since 1987. Longitudinal follow-up of SCD case patients
diagnosed by NBS traditionally has been carried out through
5 years of age by NBS follow-up staff in collaboration with the
Sickle Cell Disease Association of America, Michigan Chapter
(SCDAA-MI). SCDAA-MI is a community-based organization
whose contract is funded through Michigan’s NBS fee to
provide medical management and support to families of
children in Michigan with SCD. As part of the RuSH project, the
Michigan Hemoglobinopathy Surveillance Quality Improvement
Program (MiHemSQIP) expanded hemoglobinopathy followup throughout the lifespan by enhanced monitoring of
comorbidities, service use, and patient outcomes.

Michigan’s HSA questionnaire was adapted from the individual
utilization questionnaire created by the Sickle Cell Disease
Treatment Demonstration Program, and modified over time
to specifically meet the needs of the state. Development and
Implementation of the HSA would not have been possible
without the SCDAA-MI or the Michigan Hemoglobinopathy
Quality Improvement Committee (MiHemQIC).
The MiHemQIC provided critical insight in the development of
the HSA, and continues to provide feedback on a regular basis.

Benefits
The HSA has been included as part of regular follow-up for all
SCD case patients detected via newborn screening since March
2011 in an electronic, Web-based application via the Michigan
Care Improvement Registry (MCIR). The hemoglobinopathy
module of MCIR allows patients to be managed efficiently
by SCDAA-MI staff and NBS follow-up staff, and could be
expanded to include clinicians. The electronic HSA application
was later launched within the MCIR module for all children 1
through 5 years of age initially detected by NBS, and has been
expanded to include older children and adults, such as those
who are not detected through NBS. This computerized form for
self-reported or clinically verified health information allows for
real-time data extraction and quality improvement. Aggregate
results are available immediately to SCDAA-MI patient
advocates and staff, providing valuable feedback for provision
of services. Developing the MCIR module and HSA through
RuSH has allowed for ongoing validation and evaluation of the
assessment, with potential for significant quality improvement
as the HSA is expanded to include a larger population.

Michigan developed a health status assessment (HSA)
to measure access to care, disease complications, health
care use, financial status, and educational status among
people in Michigan with SCD. The HSA provides annual
self-reported information on patients, in order to learn more
about Michigan’s population with SCD, provides feedback
on educational initiatives provided by the SCDAA-MI, and
facilitates conversation among patients and their families about
important health issues related to SCD.
Patient advocates employed by the SCDAA-MI work with
families from the main office in Detroit, as well as four regional
offices throughout Michigan, to ensure that all children with
SCD are receiving proper care and services. Beginning in 2011,
patient advocates included the HSA as part of their followup protocol for families of children with SCD. Currently, the
assessment is used as a surveillance tool for case patients of all
ages. Parents answer the questions by telephone or in person;
patients respond for themselves if they are 18 years of age or
older. Patients with SCD not detected by NBS since 1987, adult
SCD patients, and those born outside of Michigan are often
identified through clinic referral or word of mouth, and may be
included in the HSA.
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Outcomes

Next Steps

During the first 6 months of implementation, 135 assessments
were completed by patient advocates across the state.
As each HSA is conducted, important conversations often
occur between parents of children with SCD and SCDAAMI follow-up staff on topics that might not have come up
otherwise: vision screening, hydroxyurea therapy, nutritional
supplements, and bone marrow transplants. Conversations
about these issues come up naturally, allowing for an
impromptu educational session during the data collection
process for participating families.

As Michigan continues to improve the MCIR sickle cell
application, there is hope of building integrated report-making
tools that will provide aggregate and individual-level data to
SCDAA-MI staff.
Contact Info
William Young, PhD
Michigan Department of Community Health
E-mail: youngw@michigan.gov
Phone: 517-335-8938
MiHemSQIP Website: www.michigan.gov/rush

Lessons Learned

Words from the Field

The questionnaire is modified and adapted continually for
quality improvement by MiHemSQIP staff as more HSAs are
conducted. All involved patient advocates have agreed on
and use the same questionnaire. Original plans for annual
assessments were not feasible, and the MiHemSQIP currently
is modifying the assessment to be conducted once every 2
years, with the first HSA being conducted with parents, inperson or by telephone when children identified by NBS are
12 months of age.

“Our families are excited to hear about the RuSH
program and eager to “stand up and be counted”.
We have found that the health status assessment
frequently has the added value of initiating an
impromptu mini education session on hydroxyurea,
bone marrow transplant, transfusions, vitamin
supplements . . . the list goes on and on.”
— Wanda Whitten-Shurney,
Executive Director, Sickle Cell Disease Association of America,
Michigan Chapter
“Michigan’s hematologists have been actively involved
with every step of HSA development as part of their
advisory group duties. Often, their response to content
during meetings has led to vibrant conversations on
specific treatment experiences related to sickle cell
disease, inadvertently improving quality of care and
best practices for hematology throughout our state.”
— Robin O’Neill,
Michigan Hemoglobinopathy Surveillance & Quality
Improvement Coordinator
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Garnering State-wide Support for RuSH:
Regional Provider Meetings in New York
Program Overview

yy Opportunities for in-person interaction and relationship
building between the project staff, community, and
providers.

The New York RuSH project team launched a community
outreach program in summer 2011 to achieve one of the
project’s objectives: to identify at-risk populations with
hemoglobinopathies in New York State (NYS). This program,
a collaboration of the RuSH project team, the RuSH advisory
committee, and a community-based organization—the
Cooley’s Anemia Foundation—focused on (1) outreach via
regional meetings to community-based health care providers
across the state who specialize in hemoglobinopathies and (2)
administration among providers of a survey with questions
about characteristics of hemoglobinopathy specialty care
centers (HgbSCCs) and the degree of clinical information
available regarding affected patients, including confirmatory
diagnoses, comorbidities, and health care use.

yy Demonstration of the feasibility of obtaining clinical data
from the HgbSCCs for RuSH.

Outcomes
A database containing 258 providers representing 63 HgbSCCs
across NYS was constructed. All providers were contacted
and invited to the New York RuSH regional meetings. In fall
2011, two regional meetings were conducted in the New
York City area; three providers representing three HgbSCCs
and six providers representing five HgbSCCs participated in
the meetings in Brooklyn and Manhattan, respectively. Only
five providers registered for the meetings in the upstate New
York area (three in Albany and two in Syracuse). Due to low
registration in this area, registrants were invited to attend a
meeting in Herkimer, New York, which is located geographically
between Albany and Syracuse. Unfortunately, the meeting was
canceled due to travel complications following the devastation
caused by Hurricanes Irene and Lee.

Resources Needed
A survey was developed to assess the long-term health care
status of people with hemoglobinopathies, identify clinical
information collected at HgbSCCs, and explore the possibility of
sharing and accessing collected clinical data. The brief survey,
which consisted of 16 close-ended questions, was filled out by
the participating health care providers at the regional meetings.
It also was sent via e-mail to providers who did not attend the
regional meetings. Project staff planned and conducted the
regional meetings and developed and administered the survey.
The cost of these activities included staff preparation time,
travel, follow-up meetings with registrants and participants,
meeting spaces, equipment rentals, handouts, materials, and
the annual service charge for the online survey tool.

After the regional meetings, an email containing a brief
introduction to the survey, the Centers for Disease Control
and Prevention’s RuSH project fact sheet, and an executive
summary about the New York RuSH project, along with a
Web link to the online survey, was sent to the 249 providers
representing 55 HgbSCCs who did not attend a regional
meeting. Two follow-up emails were sent to non-responders in
2-week intervals as a reminder to complete the online survey.
Reminder calls also were made to complete the survey through
a telephone interview. To date, 90 providers representing
49 HgbSCCs have completed the survey, resulting in a 78%
response rate (49/63 HgbSCCs). Implementation of the regional
meetings has helped achieve the main objectives of the
project’s outreach efforts, as well as jumpstarted fulfillment of
the overall RuSH program objective.

Benefits
The most notable benefits of the regional meetings were:

yy Enhanced collaboration among the project team members,
advisory committee members and community-based
organizations.
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Contact Information
Ying Wang, PhD, MPH
New York State Department of Health
wxy01@health.state.ny.us
(518) 402-7716
NY RuSH website: http://www.wadsworth.org/newborn/RuSH/
rush_overview.html

Project staff must work closely with clinicians and staff at the
HgbSCCs to facilitate the Institutional Review Board application
and approval process for collecting and sharing clinical data.
The process of providing all necessary documents, guidance,
and assistance is labor intensive. Preparing a thorough list
of essential data elements and conducting active follow-up
to obtain timely progress updates are critical to successful
outreach efforts with community-based HgbSCCs and
providers across NYS.

Words from the Field
“Collaboration: Key to Success for RuSH! - Case
ascertainment from multiple sources/programs with
collaborative efforts is a crucial step to establish a
population-based registry and surveillance system for
hemoglobinopathies.”
— New York RuSH Project Team

Next Steps
The New York RuSH project team will continue outreach efforts
with community-based HgbSCCs and clinicians who provide
care to hemoglobinopathy patients across NYS. In-person
regional meetings in downstate (excluding New York City)
and upstate New York areas will be planned and conducted.
Ad hoc webinars or teleconferences on topics of interest to
collaborative participants will be organized. Project staff plan to
analyze survey results and prepare a summary report to share
with the HgbSCCs and the RuSH project collaborators.

“Community outreach provides opportunities for inperson interaction and relationship-building between
the project staff and health care providers for effective
collaboration on RuSH project.”
— Dr. Ying Wang,
New York State Department of Health
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Faith-based Initiative:
North Carolina’s Approach to Community Outreach
for Hemoglobinopathies
Overview

represents over 1,700 Black or African-American congregations,
and there are 13 Greek Orthodox Churches in North Carolina,
all strategically located in major cities with large
Greek communities.

The initial collaborators in North Carolina‘s RuSH program
included community-based organizations and medical centers
with expertise in sickle cell disease(SCD) and thalassemia,
along with the Governor’s Council on Sickle Cell Disease and
other Related Disorders. As the program progressed, the
North Carolina Community Partnerships and Health Education
Workgroup formalized and developed a plan to increase
awareness and education related to SCD and thalassemia in
North Carolina through a faith-based initiative.

An educational toolkit was developed, with input from various
faith leaders, containing a program overview, brochures, church
fans, bulletin inserts, and a DVD. A Microsoft® PowerPoint
presentation for faith-based audiences also was developed and
delivered by a representative of the program (i.e., sickle cell
educator counselors, community-based organization members,
or medical center staff). The state program’s education
consultant provided programmatic oversight.

The North Carolina Faith-based Initiative (NCFI) was established
in 2011 to enhance educational and outreach strategies
involving key faith-based communities. The goal of the
initiative is to build a systematic approach for including faithbased organizations in hemoglobinopathy awareness and
education activities by:

Ample staff time and leadership are required to facilitate
partnerships with faith-based organizations to develop the
best educational approach for each organization. Partnership
meetings were held to plan, coordinate, and schedule activities
with key stakeholders. Staff trainings were used to develop
critical messages, ensuring consistent delivery. Training
expenses were attributed to staff time, travel, and conducting
follow-up sessions to strengthen future programs. A toolkit of
materials, general travel expenses, website postings, equipment
and supplies should be considered. A significant cost savings
was achieved through a partnership with the Cooley’s Anemia
Foundation, which provided technical assistance, educational
materials, and training about thalassemia at no cost.

yy Partnering with governing bodies of faith-based institutions
of all sizes.

yy Working with the medical community for technical
assistance and support.

yy Enhancing faith-based partnerships through alliances with
community-based organizations and regional educator
counselors.

yy Utilizing the Cooley’s Anemia Foundation for thalassemia
expertise and education materials.

Benefits

Resources Needed

The NCFI provides a consistent outreach message to faithbased organizations. SCD and thalassemia education is
included in church health programs and provides a platform
for a public health message. This initiative also provides an
opportunity to identify new clients (individuals living with
SCD or thalassemia) and those who have been lost to followup. The faith-based initiative creates a support system for
individuals with SCD and thalassemia and is a cost-effective
method to increase awareness and education through ongoing
partnerships and networking.

This project began by formalizing partnerships with statewide
faith-based organizations to garner participation and support.
Initial collaborations included the General Baptist State
Convention of North Carolina’s Center for Health and Healing
and the North Carolina Greek Orthodox Archdiocese, because
of high SCD and thalassemia prevalence rates among Black or
African-American and Greek populations, respectively.
The General Baptist State Convention of North Carolina

22

Registry and Surveillance System for Hemoglobinopathies

Outcomes

Contact Information
Belinda D. Pettiford, MPH
North Carolina Department of Health and Human Services
Belinda.pettiford@dhhs.nc.gov
919-707-5699
NC RuSH Website: www.ncsicklecellprogram.org

Preliminary data have indicated that faith-based communities
are receptive to this approach. Information gained from
the participant evaluation tool was favorable, with 90% of
participants demonstrating an increased knowledge of SCD
and thalassemia after attending the session.

Words from the Field

Lessons Learned

“We want to empower people with knowledge.
We want to give information that will allow good
decision- making. We want to empower people to take
charge of their lives. The information that you provide
allows us to give that hand up to a healthier life.”
— Rev. Warren
of Little Rock AME Zion Church,
Charlotte, NC

It is important to provide culturally appropriate and
personalized information based on religious practices.
Identifying an advocate in the faith-based setting, such as a
gatekeeper or pastor, as a point of contact for the program
is key for effective communication. Connecting with
parishioners who are affected by SCD or thalassemia can be
a way to personalize the connection with the congregation.
Sustainability of the program is an important discussion to have
with key leaders, so efforts do not dissolve with time or change
of leadership.

“This type of outreach connects with one’s soul, and
creates long-lasting relationships; and our efforts
prove that.”
— Aziz Coleman,
Sickle Cell Educator Counselor, Community Health Interventions
and Sickle Cell Agency

Next Steps
The NCFI includes plans to expand activities to other
traditional, nontraditional, and nondenominational faithbased organizations. NCFI activities will be evaluated through
surveys and focus groups, evaluations, and key informant
interviews. The program will examine how this project
aligns with the White House Office of Faith-based and
Neighborhood Partnerships to determine future opportunities
for enhancement and expansion of awareness and education of
hemoglobinopathies.

“The presentation to our women’s group on
thalassemia was very educational. It answered
questions that people thought that they had the
answers to but were wrong. Now they are giving the
right information to their daughters, nieces, and
other relatives.”
— Ann-Marie Dentiste,
Chapter President, Ladies Philoptochos Society, Annunciation
Greek Orthodox Church,
Winston-Salem, NC
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Answering the Call:
Pennsylvania’s Toll-free Phone Number for
Hemoglobinopathy Health Care Referrals
Program Overview

churches, schools, modes of public transportation, and area
health care provider sites. The primary resources needed are a
vendor to provide telephone service and partnerships between
community-based organizations across the state and the state
health department. Various personnel with the necessary
credentials and appropriate training are needed to answer the
calls, complete the script and intake forms, make referrals, and
follow up on the callers’ care. The cost of this program depends
heavily on the telephone service used, the number of staff with
the required credentials, advertisement of the toll-free number,
and any modifications to data systems to provide required
reporting.

One of Pennsylvania’s goals is to provide a mechanism to
directly reach individuals with a hemoglobinopathy diagnosis.
The unique partnership between the Pennsylvania RuSH
Team, hospitals, and community-based organizations has
resulted in a collaboration to establish a toll-free number
(1-855-4SICKLE) that allows individuals with sickle cell disease
(SCD) or thalassemia to connect with regional communitybased programs and comprehensive hemoglobinopathy
programs, and enroll in appropriate care, as well as the state
hemoglobinopathies database.
Following a greeting and brief explanation of the purpose
of the toll-free number, callers will be prompted to use their
touch-tone key pad to indicate whether they have SCD or
thalassemia and to enter their ZIP Code. Calls will be routed
to the community-based organization (CBO) that is best
prepared to service the ZIP Code indicated. CBOs will use a
script and intake form that includes questions to ascertain
contact and demographic information; diagnosis and current
source of medical care and insurance; and how the caller heard
about the toll-free number. The contacted organization also
will coordinate referral appointment scheduling and, when
necessary, provide someone to accompany the individual to the
appointment.

Benefits
The primary benefit of the proposed toll-free number will be its
ability to provide a direct connection between individuals with
hemoglobinopathies and comprehensive care. This program
also will give those individuals an opportunity to be included
in state prevalence estimates, as well as generate high-quality
individual-level surveillance data. Pennsylvania anticipates
the data will be informative regarding demographics, barriers
to care, and the ability to conduct Geographic Information
System (GIS) mapping for populations of individuals with
hemoglobinopathies to provide effective and continuous care.

Callers after business hours will be prompted to leave a call
back number, which will be retrieved and returned on the
next business day. Aggregate descriptive data of the toll-free
number use will be obtained and each organization will report
to the Pennsylvania Department of Health with information
obtained through the call script and intake form and the
outcome of health care referrals.

Outcomes
The anticipated outcomes are:

yy

More accurate and reliable information on the number of
individuals and families living with SCD and thalassemia.

yy Improved knowledge and awareness about SCD and
thalassemia.

Resources Needed

yy Increased access to health care, education, treatment, and
supportive services to individuals and families affected by
SCD and thalassemia.

Flyers, posters, and radio advertisements have been developed
to advertise the toll-free number. Marketing has been targeted
to media outlets most popular among key ethnic groups, as
well as frequently accessed locations such as supermarkets,

By connecting patients with comprehensive care centers, the
information obtained by the state will be more reliable for
predictions for state resource needs and allocations.
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Words from the Field

Appropriations should be made to anticipate delays in program
implementation, such as working with the telephone service
provider and coordinating the logistics of connecting each
caller with the necessary service and follow-up. A thorough
and organized process is needed to facilitate a clear and
comprehensive plan for disseminating information about the
toll-free line to consumers, making sure all health care providers
are on board with the procedures and the technical aspects of
the toll-free line are working properly.

“As many think of sickle cell as the forgotten disease,
the RuSH Program dispels that notion. Call the tollfree number and be informed.”
— Stanley Simpkins,
Executive Director, Sickle Cell Disease Association of America,
Philadelphia/Delaware Valley Chapter
“If you have sickle cell disease or thalassemia . .
. we’re here and WE CARE! Call 1-855-4SICKLE
TODAY! Through the creation of this 1-855-4SICKLE
line, we are committing ourselves to be a resource for
all persons with sickle cell disease and thalassemia.
It is our intent to be consistent and effective in
connecting persons to the resources that they need.
Whether that means answering a question for a
person who has been in comprehensive care for some
time, or for connecting newly identified persons to
comprehensive care for the first time, we’re here and
we care!”
— Andrea Williams,
Executive Director, Children’s Sickle Cell Foundation, Inc.

Next Steps
An assessment of the first month’s activities for the toll-free
line will be incorporated into ongoing operations and training.
Pennsylvania anticipates initial data and feedback on the tollfree telephone number use in March 2012. The toll-free number
has been proposed as an ongoing activity for Pennsylvania’s
comprehensive hemoglobinopathy programs beyond the life
of the RuSH grant. The toll-free number concept was chosen
because of the ease of access for individuals participating in
surveillance and any future registries, and because it is a model
that may be replicable from a statewide to a national effort.

“Why should surveillance reach out to patients with
hemoglobinopathies? Because they may not have
access to quality care and may be suffering from
disease- related complications.”
— Dr. Lakshmanan Krishnamurti,
Director of Sickle Cell Program, Children’s Hospital of Pittsburgh

Contact Information
William Cramer, M.Ed.
Pennsylvania Department of Health
wcramer@pa.gov
(717) 783-8143
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For more information contact:
Centers for Disease Control and Prevention
National Center on Birth Defects and Developmental Disabilities
Division of Blood Disorders
1600 Clifton Road MS E-87
Atlanta, GA 30333
800-CDC-INFO (800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day
cdcinfo@cdc.gov

National Center on Birth Defects and Developmental Disabilities
Division of Blood Disorders

